Which stocks are moving on Tuesday?
By Mill Chart
Last update: Apr 30, 2024
Which stocks are experiencing notable movement on Tuesday?
Gainers
| Ticker | Change | Comment |
|---|---|---|
| AKLI | 74.07% | Investors witnessed a remarkable 74.07% rise in AKILI INC's (NASDAQ:AKLI) shares, which climbed to $0.41 during Tuesday's session. Earlier today the company had a press release: Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results. |
| SWVLW | 46.26% | PIVOTAL HOLDINGS CORP -CW27's (NASDAQ:SWVLW) stock price increased by 46.26% to $0.02. Shareholders saw the stock price going 47.0% higher in the past 3 months. |
| AGBA | 46.17% | AGBA GROUP HOLDING LTD's (NASDAQ:AGBA) shares rose 46.17% to $3.44. A press release (Building a Digital Economy Titan: AGBA and Triller Combine in $4 Billion Merger) was released earlier today. |
| WGS | 45.0% | GENEDX HOLDINGS CORP's (NASDAQ:WGS) shares soared 45.0% to $15.95 during Tuesday's session. Yesterday the company had a press release: GeneDx Reports First Quarter 2024 Financial Results and Business Highlights. |
| CYCC | 44.12% | Positive market sentiment drove CYCLACEL PHARMACEUTICALS INC's (NASDAQ:CYCC) stock price up by 44.12% to $1.96 during Tuesday's session. Earlier today the company had a press release: Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules. |
| WKSP | 42.37% | WORKSPORT LTD's (NASDAQ:WKSP) stock price displayed strong growth, advancing 42.37% and reaching $0.84 during Tuesday's session. In the last 3 months the share price dropped with 56.3%. |
| ELYM | 41.14% | ELIEM THERAPEUTICS INC's (NASDAQ:ELYM) shares soared 41.14% to $7.08 during Tuesday's session. Shareholders saw the stock price going 79.29% higher in the past month. |
| AGBAW | 40.45% | AGBA ACQUISITION LTD -CW24 (NASDAQ:AGBAW) witnessed a notable 40.45% uptick in its shares, reaching $0.28 during Tuesday's session. In the last month the share price increased with 1.0K%. |
| SWVL | 40.32% | Exciting news for SWVL HOLDINGS CORP (NASDAQ:SWVL) as its stock price surged 40.32% to $14.2 during Tuesday's session. Earlier today the company had a press release: Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth in Gross Profit. |
| DARE | 25.36% | DARE BIOSCIENCE INC's (NASDAQ:DARE) stock price increased by 25.36% to $0.35. Shareholders saw the stock price going 43.06% lower in the past month. |
Our top gainers page will show you the full list.
Losers
| Ticker | Change | Comment |
|---|---|---|
| LICN | -30.54% | LICHEN CHINA LTD- A's (NASDAQ:LICN) stock price faced a 30.54% decline, reaching $1.41 during Tuesday's session. Shareholders saw the stock price going 86.24% higher in the past month. |
| NRXP | -27.32% | NRX PHARMACEUTICALS INC's (NASDAQ:NRXP) stock price faced a 27.32% decline, reaching $2.58 during Tuesday's session. The stock is trading 32.38% lower than a month ago. |
| CHGG | -24.9% | During Tuesday's session, CHEGG INC's (NYSE:CHGG) shares took a tumble, falling 24.9% to $5.38. Yesterday the company had a press release: Chegg Announces Appointment of Nathan Schultz as Chief Executive Officer. |
| MED | -22.82% | There was a notable decline in MEDIFAST INC's (NYSE:MED) shares, as they dropped 22.82% to $27.41 during Tuesday's session. Yesterday the company had a press release: Medifast Announces First Quarter 2024 Financial Results. |
| LUCY | -20.83% | INNOVATIVE EYEWEAR INC's (NASDAQ:LUCY) stock price faced a 20.83% decline, reaching $0.19 during Tuesday's session. Shareholders saw the stock price going 21.09% lower in the past month. |
| CSLR | -19.75% | COMPLETE SOLARIA INC's (NASDAQ:CSLR) stock price decreased by 19.75% to $0.59. A press release (Complete Solaria to Report Fourth Quarter 2023 and First Quarter 2024 Financial and Operational Results on May 2, 2024) was released earlier today. |
| HEES | -17.43% | There was a notable decline in H&E EQUIPMENT SERVICES INC's (NASDAQ:HEES) shares, as they dropped 17.43% to $48.9 during Tuesday's session. yesterday the company released their earnings. In the last 6 months the stock gained 36.01%. |
| SGBX | -17.16% | There was a notable decline in SAFE & GREEN HOLDINGS CORP's (NASDAQ:SGBX) shares, as they dropped 17.16% to $0.12 during Tuesday's session. Earlier today the company had a press release: Correction: Safe & Green Holdings Corp Announces Reverse Split of the Company’s Common Stock. |
| BKKT | -17.12% | BAKKT HOLDINGS INC's (NYSE:BKKT) stock price faced a 17.12% decline, reaching $8.26 during Tuesday's session. In the last month the share price increased with 2.0K%. |
| ANVS | -17.03% | ANNOVIS BIO's (NYSE:ANVS) stock price is declining with 17.03% to a price of $6.04. A press release (Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease) was released yesterday. |
To see the full list of top losers you can use our top losers page.
NRX PHARMACEUTICALS INC
NASDAQ:NRXP (5/9/2024, 10:35:30 AM)
2.81
-0.01 (-0.35%)
NRXP News
a day ago - InvezzNRx Pharmaceuticals eyes first commercial revenue in 2024, announces breakthroughs in bi-annual milestone updateMichigan, United States, April 29th, 2024, FinanceWire NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and […]
a day ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...
2 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced...
3 days ago - Get NewsFinal Clinical Trial Results Show Superior Safety and Efficacy for NRX-101; Plans to Seek Accelerated Approval for Bipolar Depression and Schizophrenia: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
3 days ago - NRx Pharmaceuticals, Inc.NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar DepressionBoth drugs demonstrated > 50% response for treating depression. NRX-101 demonstrated a mean 76% reduction in symptoms of akathisia compared to lurasidone that...
8 days ago - ChartmillThese stocks are moving in today's pre-market sessionGet insights into the top gainers and losers of Wednesday's pre-market session.
9 days ago - ChartmillTuesday's after hours session: top gainers and losersWhich stocks are moving after the closing bell on Tuesday?
9 days ago - ChartmillWhat's going on in today's sessionWondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
9 days ago - ChartmillWhich stocks are moving on Tuesday?Which stocks are experiencing notable movement on Tuesday?
9 days ago - ChartmillWhich stocks are gapping on Tuesday?Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
9 days ago - NRx PharmaceuticalsNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar DepressionNRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75%...
21 days ago - InvestorPlaceWhy Is Bio-Path (BPTH) Stock Up 89% Today?Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.
